Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers O > Headlines for Oscient Pharmaceuticals Corp. > News item |
Oscient Pharmaceuticals asks court for 15-day exclusivity extension
By Lisa Kerner
Charlotte, N.C., Jan. 22 - Oscient Pharmaceuticals Corp. requested a 15-day extension to its exclusive periods to file a plan of reorganization and solicit votes on the plan, according to a Friday filing with the U.S. Bankruptcy Court for the District of Massachusetts.
The company wants to extend its exclusive plan-filing period to Feb. 10 from Jan. 26 and the solicitation period to April 9 from March 25.
Oscient said it needs the extra time to continue negotiations with debtor Guardian II Acquisition Corp.'s secured lender Paul Royalty Fund Holdings II to resolve issues related to the allocation of asset sale proceeds, as well to resolve intercompany claims between Oscient and the Guardian estates.
The company also asked for an emergency determination of the motion because its existing exclusive filing period expires shortly on Jan. 26.
Oscient, a Waltham, Mass., commercial-stage pharmaceutical company, filed for bankruptcy on July 13, 2009. Its Chapter 11 case number is 09-16576.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.